iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionLarson Financial Group LLC
Latest Disclosed Ownership3,132 shares
Latest Disclosed Value $ 528,772
Larson Financial Group LLC reports 15.27% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 15, 2026 - Larson Financial Group LLC filed a 13F-HR form disclosing ownership of 3,132 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $528,772 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 2,717 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 15.27% during the quarter. The current value of the position is $410,449 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,132 415 15.27 529 15.28 0.0159
2026-02-06 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,717 60 2.26 458 19.58 0.0153
2025-11-14 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,657 257 10.71 384 26.40 0.0134
2025-08-08 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,400 494 25.92 304 24.69 0.0122
2025-05-02 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,906 153 8.73 244 5.19 0.0115
2025-02-07 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,753 102 6.18 232 -3.75 0.0120
2024-11-12 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,651 60 3.77 240 10.09 0.0136
2024-08-02 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,591 6 0.38 218 0.46 0.0149
2024-05-03 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,585 153 10.68 217 11.86 0.0168
2024-02-01 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,432 57 4.15 194 15.48 0.0170
2023-11-03 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,375 200 17.02 168 12.75 0.0165
2023-08-03 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,175 96 8.90 149 7.19 0.0149
2023-05-04 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,079 5 0.47 139 -0.71 0.0151
2023-02-03 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,074 -41 -3.68 141 7.69 0.0169
2022-11-03 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,115 1,000 869.57 130 828.57 0.0185
2022-08-04 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 115 0 0.00 14 -6.67 0.0024
2022-05-05 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 115 -38 -24.84 15 -34.78 0.0024
2022-02-03 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 153 0 0.00 23 -8.00 0.0036
2021-11-04 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 153 0 0.00 25 0.00 0.0050
2021-08-10 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 153 38 33.04 25 47.06 0.0058
2021-05-06 2021-03-31 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 115 0 0.00 17 0.00 0.0050
2021-04-08 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 115 0 17 0.0058
2021-01-14 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 115 70 155.56 17 183.33 0.0058
2020-10-08 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 45 0 0.00 6 0.00 0.0025
2020-07-10 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 45 0 0.00 6 20.00 0.0029
2020-04-09 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 45 0 0.00 5 0.00 0.0031
2020-01-10 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 45 0 0.00 5 25.00 0.0029
2019-10-11 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 45 0 0.00 4 -20.00 0.0026
2019-07-16 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 45 0 0.00 5 0.00 0.0037
2019-04-05 2019-03-31 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 45 0 0.00 5 25.00 0.0040
2019-04-04 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 45 0 4 0.0037
2019-02-07 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 45 45 4 0.0037
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.